Thoracoscopic lung surgery
Conditions
Interventions
Ropivacaine group (Group R):Before the induction of general anesthesia, ultrasound-guided thoracic paravertebral nerve block was performed. Ropivacaine group: 66 mg of ropivacaine (20 ml, 0.33%) was i
Low-dose liposome bupivacaine group (LL group):Before the induction of general anesthesia, ultrasound-guided thoracic paravertebral nerve block was performed. Low-dose liposome bupivacaine group: 133
High-dose liposome bupivacaine group (HL group):Before induction of general anesthesia, ultrasound-guided thoracic paravertebral nerve block was performed. High-dose liposome bupivacaine group: 266 mg
Sponsors
The First Affiliated Hospital of Zhengzhou University
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: Patients aged 18-65 years with American Society of Anesthesiologists (ASA) physical status I or III scheduled for elective thoracoscopic partial lung resection under general anesthesia in the First Affiliated Hospital of Zhengzhou University from May 2025 to August 2025 were enrolled.
Exclusion criteria
Exclusion criteria: 1. previous chest surgery; 2. diagnosed mental illness; 3. have a history of drug or alcohol abuse; 4. body mass index (BMI) 30kg/m^2; 5. severe liver and kidney dysfunction; 6. coagulation disorders; 7. infection at the puncture site; 8. long-term use of chronic analgesic drugs; 9. spinal deformity; 10. difficulty in communication.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Resting and active NRS pain scores; | — |
Secondary
| Measure | Time frame |
|---|---|
| Cumulative consumption of opiates;Time to remove chest drain;Length of hospitalization;Moderate-to-severe pain; | — |
Countries
China
Contacts
Public ContactWang Yanping
The First Affiliated Hospital of Zhengzhou University
Outcome results
None listed